Health tech companies Aetion and Cegedim have agreed to combine their data platforms together, to allow clients to gauge how their therapies are performing in the real world.
Use of real-world evidence is becoming increasingly common to aid the clinical development process and provide important data for pricing discussions once medicines have been approved.
